Literature DB >> 12502667

Prevalence and concomitants of glucose intolerance in European obese children and adolescents.

Cecilia Invitti1, Gabriele Guzzaloni, Luisa Gilardini, Francesco Morabito, Giancarlo Viberti.   

Abstract

OBJECTIVE: The worldwide increase in the prevalence of childhood obesity is reaching epidemic proportions and is associated with a dramatic rise in cases of type 2 diabetes. The prevalence of glucose intolerance and its determinants and the relation of cardiovascular risk factors with levels of glycemia and degree of obesity were studied in grossly obese children of European origin. RESEARCH DESIGN AND METHODS: A total of 710 grossly obese Italian children (SD score [SDS] of BMI 3.8 +/- 0.7) aged 6-18 years, including 345 male subjects, underwent an oral glucose tolerance test. Insulin resistance and insulin secretion were estimated using the homeostasis model assessment for insulin resistance and the insulinogenic index, respectively. Fibrinogen, C-reactive protein, lipids, and uric acid were measured. The 2-h postload glucose and degree of obesity, calculated as the SDS of weight/height(2), were used as dependent variables.
RESULTS: The prevalence of glucose intolerance was 4.5%. Insulin resistance (P < 0.0001), impaired insulin secretion (P < 0.0001), and diastolic blood pressure (BP) (P < 0.05) were significantly and independently related to 2-h postload glucose values. The degree of obesity did not relate to insulin resistance but was independently correlated with inflammatory proteins, uric acid, and systolic BP, variables that were often abnormal in this population.
CONCLUSIONS: In these grossly obese children, both insulin resistance and impaired insulin secretion contribute to the elevation of glycemia, and the degree of obesity is related to cardiovascular risk factors independently of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502667     DOI: 10.2337/diacare.26.1.118

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

1.  Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study.

Authors:  Aaron S Kelly; Andrea M Metzig; Kyle D Rudser; Angela K Fitch; Claudia K Fox; Brandon M Nathan; Mary M Deering; Betsy L Schwartz; M Jennifer Abuzzahab; Laura M Gandrud; Antoinette Moran; Charles J Billington; Sarah J Schwarzenberg
Journal:  Obesity (Silver Spring)       Date:  2011-11-10       Impact factor: 5.002

Review 2.  The major diabetes prevention trials.

Authors:  Jaakko Tuomilehto; Jaana Lindström
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 4.810

3.  Diabetes may be undetected in many children in the UK.

Authors:  Tim Lobstein; Rachel Leach
Journal:  BMJ       Date:  2004-05-22

4.  Hyperuricemia and gout following pediatric renal transplantation.

Authors:  Giuseppina Spartà; Markus J Kemper; Thomas J Neuhaus
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

5.  -to: Ong KK, Petry CJ, Emmett PM et al.; ALSPAC study team (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47:1064-1070.

Authors:  C Invitti; L Gilardini; G Mazzilli; A Sartorio; G C Viberti
Journal:  Diabetologia       Date:  2004-11-24       Impact factor: 10.122

6.  Prevalence of the insulin resistance syndrome in obesity.

Authors:  R M Viner; T Y Segal; E Lichtarowicz-Krynska; P Hindmarsh
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

7.  Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity.

Authors:  Yasar Sen; Nurgun Kandemir; Ayfer Alikasifoglu; Nazli Gonc; Alev Ozon
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

8.  Clinical and biochemical manifestations of syndrome X in obese children.

Authors:  Efimia Papadopoulou-Alataki; Kiriaki Papadopoulou-Legbelou; Loukas Doukas; Kiparissia Karatzidou; Aikaterini Pavlitou-Tsiontsi; Emmanouil Pagkalos
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

9.  Obesity in Irish youth: epidemiology and implications.

Authors:  F M Finucane
Journal:  Ir J Med Sci       Date:  2009-06-03       Impact factor: 1.568

10.  Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006.

Authors:  Chaoyang Li; Earl S Ford; Guixiang Zhao; Ali H Mokdad
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.